From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling

From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling

BackgroundImmune system conditions of the patient is a key factor in COVID-19 infection survival. A growing number of studies have focused on immunological determinants to develop better biomarkers for therapies.AimStudies of the insurgence of immunity is at the core of both SARS-CoV-2 vaccine devel...

Full description

Bibliographic Details
Main Authors:	Filippo Castiglione, Debashrito Deb, Anurag P. Srivastava, Pietro Liò, Arcangelo Liso
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 in-silico modeling virtual cohort SARS-CoV-2 immunosenescence
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.646972/full

Similar Items

In-silico studies of amentoflavone and its derivatives against sars-cov-2
by: Achmad, A., et al.
Published: (2021)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
by: Graham Pawelec, et al.
Published: (2021-02-01)

Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine Development
by: Vipin Ranga, et al.
Published: (2020-07-01)

Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach
by: Luis Daniel Goyzueta-Mamani, et al.
Published: (2021-06-01)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
by: Graham Pawelec, et al.
Published: (2020-04-01)

Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
by: Hani A. Alhadrami, et al.
Published: (2021-05-01)

Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease
by: Cafiero C, et al.
Published: (2020-10-01)

Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
by: Mohammad M. Al-Sanea, et al.
Published: (2021-07-01)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.

Magical bullets from an indigenous Indian medicinal plant Tinospora cordifolia: An in silico approach for the antidote of SARS-CoV-2
by: Sampark S. Thakkar, et al.
Published: (2021-03-01)

An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population
by: Andrés Felipe Cuspoca, et al.
Published: (2021-06-01)

In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
by: Anvitha, D., et al.
Published: (2022)

In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants
by: Haruna I. Umar, HND, et al.
Published: (2021-04-01)

In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor
by: Doni Dermawan, et al.
Published: (2021-01-01)

Dermaseptin-Based Antiviral Peptides to Prevent COVID-19 through In Silico Molecular Docking Studies against SARS-CoV-2 Spike Protein
by: Taufik Muhammad Fakih
Published: (2020-07-01)

Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT‑qPCR Assays in the Context of New Variants
by: Mathieu Gand, et al.
Published: (2021-04-01)

In Silico Activity Identification of Cyclo Peptide Alkaloids from Zizyphus Spina-Christi Species Against Sars-Cov-2 Main Protease
by: Taufik Muhammad Fakih, et al.
Published: (2021-06-01)

In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
by: Arijit Bhowmik, et al.
Published: (2021-01-01)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
by: Santosh Kumar Behera, et al.
Published: (2021-01-01)

Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis
by: Ranjan K. Mohapatra, et al.
Published: (2021-03-01)

Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
by: Lucas Leite Cunha, et al.
Published: (2020-08-01)

Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain
by: Sultan F. Alnomasy
Published: (2021-07-01)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
by: Sumit Arora, et al.
Published: (2020-12-01)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01)

Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach
by: Bishajit Sarkar, et al.
Published: (2020-01-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Single base mutations in the nucleocapsid gene of SARS-CoV-2 affects amplification efficiency of sequence variants and may lead to assay failure
by: Nathaniel Storey, et al.
Published: (2021-09-01)

Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
by: Christian A. Devaux, et al.
Published: (2021-02-01)

Data on the docking of phytoconstituents of betel plant and matcha green tea on SARS-CoV-2
by: Fatimawali, et al.
Published: (2021-06-01)

Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection
by: Mathieu Gand, et al.
Published: (2020-08-01)

Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
by: Fuad Ameen, et al.
Published: (2021-10-01)

Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study
by: Abd-ElAziem Farouk, et al.
Published: (2021-06-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Molecular basis of COVID-19 pathogenesis and in silico studies of potential pharmacological treatment
by: Eduardo Rubén Lam Cabanillas, et al.
Published: (2021-03-01)

A protein interaction map identifies existing drugs targeting SARS-CoV-2
by: Claudia Cava, et al.
Published: (2020-09-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
by: Shafi Mahmud, et al.
Published: (2021-05-01)

Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
by: Hani A. Alhadrami, et al.
Published: (2021-05-01)

Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
by: Isabella Romeo, et al.
Published: (2021-01-01)